Second‐line strategies more effective than dose optimization in depression treatment

Alternative second‐line treatments for major depressive disorder led to higher response and remission rates in comparison to commonly used dose optimization in a randomized trial. The combination of a selective serotonin reuptake inhibitor (SSRI) and psychotherapy resulted in the lowest prevalence of adverse events among the studied second‐line strategies.